Single Nucleotide Polymorphism
7
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout
VDR SNPs & 25OHD Correlated With Dyslipidemia
Nuclear Factor Kappa-B (NFKB1) Polymorphism and Organ Injury After Cardiac Surgery
Folate Gene Polymorphisms and Cellular Folate Speciation Pilot Study
Association of Genetic Polymorphisms With Lipid Lowering Effects of Statin Therapy
NADPH Oxidase Polymorphisms in Obstructive Sleep Apnea Syndrome (OSAS)
Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome